Advokatfirman Lindahl advises Stille on a directed share issue of SEK 425 million in conjunction with Stille’s acquisition of Fehling
Lindahl has acted as advisor in connection with Stille AB (publ)'s directed share issue of approximately SEK 425 million. The proceeds are intended to be used to finance the acquisition of Fehling.
Fehling is a family-owned German company that develops and sells high-quality medical instruments. Fehling has a strong market position with direct operations in Germany, Switzerland, the US, Singapore, the United Arab Emirates and Malaysia.
Stille develops, manufactures and markets medical devices for specialist surgeons worldwide. Stille is one of the world's oldest medical technology companies, with a focus on surgical instruments and operating tables. The company has a stable base with a strong brand and well-known products of recognized high quality.
Pareto Securities AB has acted as Sole Manager and Bookrunner.
Lindahl's team mainly consisted of Ola Svanberg, Victoria Skoglund, Gustav Ahlgren, Jakob Josefsson and Ebba Meyer-Lie.
Do you want to know more? Contact:
Ola Svanberg
Partner | AdvokatVictoria Skoglund
Partner | AdvokatJakob Poulidas Josefsson
AssociateEbba Meyer-Lie
AssociateCarousel items
-
News articles
4/7/2025
Axel Hedberg appointed new CIO at Lindahl
Advokatfirman Lindahl is advancing its development and digitalisation journey by merging IT and Knowledge Management. The newly formed department will be led by Axel Hedberg, who has been appointed as CIO.
-
Cases and transactions
4/7/2025
Lindahl advisors to Amplex in two acquisitions
Lindahl has acted as legal advisor to Amplex in connection with the acquisition of all shares in the German company Filtertechnik Jäger GmbH and the Danish company GMV A/S.
-
Knowledge
3/27/2025
Termination Due to Poor Work Performance – How to Act Correctly as an Employer
As an employer, it can be challenging to know how to handle an employee who is not performing as expected and when it is serious enough to justify termination. The so-called LAS reform of 2022, where the term "objective grounds" was replaced with...
-
Read more news and insights?